在激活PI3K三角综合征中调节PI3K信号通路:临床视角
1Faculty of Medicine, University of Sydney, Sydney, NSW, Australia. Lucinda.Berglund@sydney.edu.au.
Journal of clinical immunology
|December 26, 2023
概括
活性酸-3-酶三角酶 (PI3Kδ) 综合征 (APDS) 是一种免疫性疾病. 本综述探讨了针对APDS治疗的PI3K通路调节,包括leniolisib.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 活性酸-3-酶三角综合征 (APDS) 是一种主要免疫缺陷,其特征是免疫调节失调.
- 导致PI3Kδ过度激活的遗传突变是APDS的根本原因.
- 目前的管理包括支持性疗法和途径调制.
研究的目的:
- 在APDS的背景下,审查PI3K路径的生物学.
- 讨论在APDS中调节PI3K通路的临床策略.
- 要突出PI3K抑制在APDS和血液恶性瘤之间的差异.
主要方法:
- 关于PI3K通路生物学的文献综述.
- 对有关APDS治疗的临床数据的分析.
- 对APDS和血液恶性瘤的治疗方法的比较.
主要成果:
- 作为一种mTOR抑制剂的西洛利木斯在某些APDS表现方面表现出有效性.
- 作为一种特定PI3Kδ抑制剂的leniolisib显示出有前途的早期临床结果.
- 有针对性的PI3Kδ抑制为APDS提供了潜在的更精确的治疗策略.
结论:
- 对PI3K路径的细微调节对于有效的APDS管理至关重要.
- 列尼奥利西布代表了针对性APDS治疗的重大进展.
- 了解PI3K通路的差异是优化APDS与血液癌症治疗的关键.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
IP3/DAG Signaling Pathway
12.1K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K


